Delivery Order SPE2DB20D2014-SPE2DB24FA85F
- Not listed
- This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,158.28 and is a Firm Fixed Price Delivery Order with a period of performance through March 5, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
- This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The $5,075.33 firm fixed-price delivery order was awarded on July 16, 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a completion date of July 17, 2025. The contract is not set aside and is part of Amerisourcebergen Drug Corp's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- The federal contract award is for the delivery of ELIQUIS 2.5 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,965.60 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of July 1, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. This contract is not set-aside and is part of a larger...
- This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The $35,970.73 firm fixed price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 16, 2025 with a completion date of July 17, 2025. The contract is not set aside. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 24, 2025, with a ceiling value of $41,479.53 and a completion date of February 25, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $11,241.95 and is a firm fixed-price delivery order, with an ultimate completion date of July 29, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not designated as a set-aside. Amerisourcebergen holds a significant...
- The federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $2,437.36 and is a Firm Fixed Price Delivery Order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and allows for the delivery of a range of pharmaceutical products and medical supplies to support military healthcare programs...
- This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $7,124.97 and is a Firm Fixed Price Delivery Order with a completion date of May 16, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and was awarded on May 15, 2025. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $28,944.21 and was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of October 31, 2024. The contract is not designated as a set-aside. Amerisourcebergen...
- This federal contract award is for the delivery of ELIQUIS 2.5 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $13,626.92 and is a firm fixed-price delivery order with an ultimate completion date of October 21, 2024. This contract is associated with a larger Indefinite Delivery...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FA85FDelivery Order
This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $25,407.82 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 22, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that specializes in supplying medical products to federal government agencies. This contract appears to be a part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.4k | 1/19/24 |